| Identification | Back Directory | [Name]
1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one | [CAS]
1795033-32-7 | [Synonyms]
Flurazepam-d10 Dihydrochloride (1.0mg/mL in Methanol)
1-[2-[bis(1,1,2,2,2-pentadeuterioethyl)amino]ethyl]-7-chloro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one | [Molecular Formula]
C21H23ClFN3O | [MOL File]
1795033-32-7.mol | [Molecular Weight]
387.88 |
| Hazard Information | Back Directory | [Description]
Flurazepam-d10 (CRM) is intended for use as an internal standard for the quantification of flurazepam by GC- or LC-MS. Flurazepam is structurally categorized as a benzodiazepine. It produces anxiolytic and sedative properties that have been implemented clinically in the treatment of insomnia but also carry a potential for misuse.1,2 This product is intended for research and forensic applications. | [Uses]
Labelled Flurazepam (F500800). Flurazepam is used as an sedative, hypnotic. This is a controlled substance (depressant). | [References]
1. Bertisch, S.M., Herzig, S.J., Winkelman, J.W., et al. National use of prescription medications for insomnia: NHANES 1999-2010 Sleep 37(2),343-349(2014).
2. Griffiths, R.R., and Johnson, M.W. Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds J. Clin. Psychiatry 66(Suppl 9),31-41(2005). |
|
|